Scientific Protein Labs

Scientific Protein Labs

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Scientific Protein Laboratories (SPL) is a long-established, privately-held CDMO with a core focus on biologics derived from natural sources and microbial fermentation. The company operates from a cGMP facility in Waunakee, Wisconsin, and has built a strong reputation as a leading global supplier of heparin and pancreatin APIs. SPL leverages its deep expertise in extraction, purification, and process development to offer end-to-end contract services, supporting client products from early development through commercial scale-up. Its business model combines the sale of proprietary specialty APIs with fee-for-service contract development and manufacturing.

AnticoagulationPancreatic InsufficiencyBiologics Development

Technology Platform

Specialized platform for extraction, isolation, and purification of APIs from biological sources (animal tissues, plants) and microbial fermentation for therapeutic proteins. Core expertise in complex natural product chemistry and cGMP manufacturing.

Opportunities

The growing biologics CDMO market and the niche demand for expertise in complex, naturally-derived therapeutics present a significant expansion opportunity.
SPL can leverage its strong regulatory track record and specialized purification platform to become a partner of choice for biotechs developing non-standard biologic modalities, driving service revenue growth beyond its core API products.

Risk Factors

Key risks include supply chain vulnerability due to reliance on animal-derived raw materials, potential for disruptive synthetic alternatives to natural products, and regulatory/compliance risks concentrated at its primary manufacturing facility.
Revenue is also somewhat concentrated in a few key API products.

Competitive Landscape

SPL competes in a specialized niche. It faces competition from other API suppliers (e.g., Bioiberica in heparin) and larger, full-service biologics CDMOs (e.g., Lonza, Samsung Biologics) that offer fermentation and cell culture services. Its key competitive advantages are decades of specific expertise in natural product extraction and purification and a reputation for deep regulatory knowledge in this complex area.